Guardian Gen 3 trials target 18,000 vehicles

Seeing Machines Ltd (AIM:SEE) is poised for significant growth in its Guardian driver safety technology, driven by an expanding partnership with Mitsubishi across Europe and North America. The European collaboration leverages upcoming GSR regulations, while in North America, the existing successful lead-generation agreement is enhanced by strategic Guardian Generation 3 trials, including a pilot with a Mitsubishi Electric fleet. CEO Paul McGlone reported a record pipeline of over 18,000 vehicles, expressing high confidence in conversion rates and anticipating improved quarterly KPIs and sustained momentum for the company.

Analysis

Seeing Machines Ltd (AIM:SEE) is demonstrating significant commercial momentum, underscored by the expansion of its partnership with Mitsubishi into Europe to capitalize on upcoming General Safety Regulation (GSR) requirements. This move mirrors a successful lead-generation model in North America, where Mitsubishi's access to customers operating over a million trucks provides a substantial addressable market. The company's sales pipeline has reached a record high of over 18,000 vehicles, a figure combining referrals from Mitsubishi and internal sales efforts. CEO Paul McGlone projects strong conversion from this pipeline, supported by a historical trial-to-engagement success rate exceeding 90%. A key strategic development is the ongoing six-week Guardian Generation 3 pilot with a Mitsubishi-owned fleet in the US, which, if converted, would serve as a powerful internal endorsement. Management has issued confident forward guidance, anticipating upcoming quarterly KPIs will show a "significant improvement" and that growth momentum will be sustained through the end of the year.

Key Decisions for Investors

• Given the record 18,000-vehicle sales pipeline and high-confidence guidance from management, investors should assess the potential for near-term revenue acceleration.
• Monitor the upcoming quarterly KPI release and any announcements regarding the conversion of the strategic Mitsubishi fleet trial, as these are key validation points for the company's growth trajectory.
• The European expansion, driven by regulatory deadlines, presents a distinct growth catalyst that could de-risk a portion of future revenues, meriting consideration in valuation models.